Barclays PLC Mustang Bio, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022
SELL
$0.46 - $7.2 $2,390 - $37,418
-5,197 Reduced 7.44%
64,690 $30,000
Q2 2022

Aug 12, 2022
SELL
$0.58 - $1.13 $7,011 - $13,659
-12,088 Reduced 14.75%
69,887 $41,000
Q1 2022

May 16, 2022
SELL
$0.73 - $1.81 $55,699 - $138,103
-76,300 Reduced 48.21%
81,975 $83,000
Q4 2021

Feb 14, 2022
BUY
$1.66 - $2.64 $113,895 - $181,135
68,612 Added 76.52%
158,275 $263,000
Q3 2021

Nov 09, 2021
BUY
$2.58 - $3.36 $102,129 - $133,005
39,585 Added 79.05%
89,663 $242,000
Q2 2021

Aug 13, 2021
SELL
$2.7 - $3.81 $89,526 - $126,331
-33,158 Reduced 39.84%
50,078 $166,000
Q1 2021

May 13, 2021
BUY
$3.02 - $5.16 $202,288 - $345,632
66,983 Added 412.13%
83,236 $277,000
Q4 2020

Feb 11, 2021
BUY
$2.66 - $4.18 $8,485 - $13,334
3,190 Added 24.42%
16,253 $61,000
Q3 2020

Nov 12, 2020
SELL
$3.01 - $3.88 $7,868 - $10,142
-2,614 Reduced 16.67%
13,063 $41,000
Q2 2020

Aug 12, 2020
BUY
$2.33 - $4.6 $15,026 - $29,665
6,449 Added 69.89%
15,677 $50,000
Q1 2020

May 13, 2020
SELL
$1.91 - $4.52 $35,552 - $84,135
-18,614 Reduced 66.86%
9,228 $25,000
Q4 2019

Feb 10, 2020
BUY
$2.57 - $4.08 $36,283 - $57,601
14,118 Added 102.87%
27,842 $114,000
Q3 2019

Nov 14, 2019
SELL
$2.74 - $4.65 $11,571 - $19,636
-4,223 Reduced 23.53%
13,724 $45,000
Q2 2019

Aug 14, 2019
BUY
$2.66 - $6.28 $35,566 - $83,969
13,371 Added 292.2%
17,947 $66,000
Q1 2019

May 15, 2019
BUY
$2.95 - $5.61 $13,499 - $25,671
4,576 New
4,576 $16,000
Q4 2018

Feb 14, 2019
SELL
$2.3 - $5.78 $13,924 - $34,992
-6,054 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$5.71 - $7.58 $27,590 - $36,626
4,832 Added 395.42%
6,054 $36,000
Q2 2018

Aug 14, 2018
SELL
$6.68 - $11.0 $41,409 - $68,189
-6,199 Reduced 83.53%
1,222 $8,000
Q1 2018

May 15, 2018
BUY
$10.14 - $12.38 $75,248 - $91,871
7,421 New
7,421 $81,000

Others Institutions Holding MBIO

# of Institutions
2
Shares Held
415K
Call Options Held
0
Put Options Held
0
View Full List

About MUSTANG BIO, INC.

MBIO Quotes by TradingView
  • Ticker MBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 105,222,000
  • Market Cap $20M
  • Description
  • Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...
More about MBIO
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email